41283-66-3Relevant academic research and scientific papers
DUAL INHIBITOR COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE
-
Page/Page column 39; 40; 42, (2016/01/01)
The present invention relates to Compounds of Formula (I) and pharmaceutical compositions containing the same. It further relates to their use in the prevention or treatment of central nervous system diseases or disorders, in particular, cognitive, neurodegenerative or neuronal diseases or disorders.
Synthesis of novel 4,6-di(substituted)amino- 1,2-dihydro-1,3,5-triazine derivatives as topical antiseptic agents
Maeda, Shirou,Kita, Toshiko,Meguro, Kanji
supporting information; experimental part, p. 597 - 600 (2009/11/30)
A series of novel 4,6-di(substituted)arnino-1,2-dihydro-1,3,5- triazine derivatives designed to have ClogP of 5.1-7.5 was synthesized and evaluated for their antiseptic properties by MIC and MBC tests against Gram-positive and Gram-negative bacteria, incl
Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues
Katsura,Nishino,Inoue,Sakane,Matsumoto,Morinaga,Ishikawa,Takasugi
, p. 143 - 150 (2007/10/03)
To extend the SAR study of guanidinothiazoles as a structurally novel class of anti-H. pylori agents, a series of 2-(substituted guanidino)-4-arylthiazoles and some 4-aryloxazole analogues were synthesized and evaluated for antimicrobial activity against
